CXL Ophthalmics
Tiffany Haynes has a diverse and extensive work experience in the ophthalmic industry. Tiffany currently holds the position of Vice President Clinical Operations at CXL Ophthalmics since March 2023. Prior to that, they spent over two decades at Johnson & Johnson Vision, where they served as the Global Director from July 2001 to March 2023. Tiffany also held the role of Senior Manager, Medical Affairs at Abbott Laboratories from June 2001 to February 2017. In addition, they have worked at Advanced Medical Optics as the Global Director, Refractive Services from 2005 to 2009. Before that, they held multiple roles at VISX, including Clinical Manager and Trainer from 2001 to 2005, and Clinical Training Consultant from 1996 to 2001. Earlier in their career, they served as the Director at Alabama Laser Eye Center from 1999 to 2001, and as the Manager, Eye Foundation Laser Center at Callahan Eye Foundation Hospital from 1996 to 2000.
Tiffany Haynes attended The University of Alabama from 1986 to 1992, where they focused on Graphic Design and Printmaking. No specific degree name was mentioned.
This person is not in any teams
This person is not in any offices
CXL Ophthalmics
CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally. Their EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for a rapid return to normal activities.CXLO was founded andis supported by experts in the field, including Michael W. Belin, MD, Chief Medical Officer, who developed the Belin ABCD Progression Display, which is able to identify keratoconus progression earlier than previously relied upon metrics.